Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year

Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year

Background: Low physical activity and high sedentary behaviour in patients with bronchiectasis are associated with hospitalisation over one year. However, the factors associated with longitudinal changes in physical activity and sedentary behaviour have not been explored. We aimed to identify clinic...

Full description

Bibliographic Details
Main Authors:	Victoria Alcaraz-Serrano, Ane Arbillaga-Etxarri, Patricia Oscanoa, Laia Fernández-Barat, Leticia Bueno, Rosanel Amaro, Elena Gimeno-Santos, Antoni Torres
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Journal of Clinical Medicine
Subjects:	bronchiectasis physical activity sedentary behaviour exacerbation
Online Access:	https://www.mdpi.com/2077-0383/10/6/1190

Similar Items

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of <i>Pseudomonas aeruginosa</i>
by: Rosario Menéndez, et al.
Published: (2020-08-01)

Factors affecting readmitted patients with acute exacerbation of bronchiectasis
by: Fatima Alhamed Alduihi, et al.
Published: (2019-01-01)

Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)
by: Amaia Artaraz, et al.
Published: (2020-01-01)

High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk
by: Wang Chun Kwok, et al.
Published: (2024-02-01)

Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis
by: Yang Liu, et al.
Published: (2021-10-01)

Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients
by: Kawamatawong T, et al.
Published: (2018-03-01)

Exacerbation Prevention and Management of Bronchiectasis
by: Joon Young Choi
Published: (2023-07-01)

Efficacy of Roflumilast in Bronchiectasis Patients with Frequent Exacerbations: A Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial
by: Siwasak Juthong, et al.
Published: (2022-01-01)

Assessment of Bronchiectasis Severity: The FACED Score versus The Bronchiectasis Severity Index (BSI)
by: Dr. Jitendrakumar A. Sisodia, et al.
Published: (2023-12-01)

Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
by: Lotte C. Terpstra, et al.
Published: (2022-12-01)

Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis
by: Hung-Yu Huang, et al.
Published: (2023-02-01)

Predicting high risk of exacerbations in bronchiectasis: the E-FACED score
by: Martinez-Garcia MA, et al.
Published: (2017-01-01)

Favorable Response to Long-Term Azithromycin Therapy in Bronchiectasis Patients with Chronic Airflow Obstruction Compared to Chronic Obstructive Pulmonary Disease Patients without Bronchiectasis
by: Choi Y, et al.
Published: (2021-03-01)

Endobronchial Therapy With Gentamicin and Dexamethasone After Airway Clearance by Bronchoscopy in Exacerbation of Non-Cystic Fibrosis Bronchiectasis: A Real-World Observational Study
by: Qiuhong Li, et al.
Published: (2021-11-01)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01)

Prognostic factors of pulmonary exacerbations severity in pediatric bronchiectasis: a retrospective cohort study
by: Heba A. Ali, et al.
Published: (2023-07-01)

Dynamic Upper and Lower Airway Microbiotas in Paediatric Bronchiectasis Exacerbations: A Pilot Study
by: David T. J. Broderick, et al.
Published: (2022-01-01)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
by: Jacky Tu, et al.
Published: (2023-09-01)

In bronchiectasis, poor physical capacity correlates with poor quality of life
by: Jarkko Mäntylä, et al.
Published: (2022-12-01)

Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity
by: Miguel Ángel Martinez-García, et al.
Published: (2022-09-01)

Active cycle of breathing technique versus oscillating PEP therapy versus walking with huffing during an acute exacerbation of bronchiectasis: a randomised, controlled trial protocol
by: Jennifer Phillips, et al.
Published: (2023-01-01)

Altered community compositions of Proteobacteria in adults with bronchiectasis
by: Guan WJ, et al.
Published: (2018-07-01)

Clinical impact of cardiovascular disease on patients with bronchiectasis
by: Shanshan Chen, et al.
Published: (2020-04-01)

Influence of Comorbidities and Airway Clearance on Mortality and Outcomes of Patients With Severe Bronchiectasis Exacerbations in Taiwan
by: Hung-Yu Huang, et al.
Published: (2022-01-01)

Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort
by: Kim EK, et al.
Published: (2021-11-01)

The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
by: L.C. Terpstra, et al.
Published: (2022-12-01)

Objectively measured physical activity and sedentary behaviour in children with bronchiectasis: a cross-sectional study
by: Barbara Joschtel, et al.
Published: (2019-01-01)

Monitoring disease progression in childhood bronchiectasis
by: Kathryn A. Ramsey, et al.
Published: (2022-09-01)

Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry
by: Ji-Ho Lee, et al.
Published: (2021-09-01)

The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies
by: Kui Li, et al.
Published: (2022-10-01)

Sputum pathogen spectrum and clinical outcomes of upper respiratory tract infection in bronchiectasis exacerbation: a prospective cohort study
by: Yan Huang, et al.
Published: (2023-12-01)

Bronchiectasis in patients with chronic obstructive pulmonary disease
by: Milesh Jung Sijapati, et al.
Published: (2018-09-01)

Bronchiectasis-associated infections and outcomes in a large, geographically diverse electronic health record cohort in the United States
by: Samantha G Dean, et al.
Published: (2024-04-01)

Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study
by: So Rae Kim, et al.
Published: (2023-05-01)

Bronchiectasis in COPD patients: more than a comorbidity?
by: Martinez-Garcia MA, et al.
Published: (2017-05-01)

Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease
by: Fathia G. Jaat, et al.
Published: (2018-05-01)

Bronchiectasis Information and Education: a randomised, controlled feasibility trial
by: Katy L. M. Hester, et al.
Published: (2020-04-01)

Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis
by: Hayoung Choi, et al.
Published: (2022-10-01)

Performance of Multidimensional Severity Scoring Systems in Patients with Post‐Tuberculosis Bronchiectasis
by: AL-Harbi A, et al.
Published: (2020-09-01)

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
by: Hyo Jin Lee, et al.
Published: (2024-01-01)